膀胱保留术治疗移行性尿路上皮癌脂肪肉瘤样变体
Bladder preserving approach for liposarcomatoid variant of transitional urothelial carcinoma.
作者信息
Singh S K, Mittal Ankur, Mukhopadhyay Abhinandan, Kakkar Nandita, Chatterjee Debajyoti
机构信息
Postgraduate Institute of Medical Education & Research, Chandigarh, India.
出版信息
Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E886-9. doi: 10.5489/cuaj.3167. Epub 2015 Dec 14.
Abstract
Urothelial carcinoma of the bladder with variant histologies is usually underdiagnosed and understaged. It is found in <25% of cases during transurethral resection of bladder tumours. The majority of cases carry a worse prognosis, with higher rates of recurrence and progression, and should be managed aggressively. Here, we report a rare case of liposarcomatoid variant of urothelial carcinoma managed by partial cystectomy and standard pelvic lymph node dissection.
摘要
具有组织学变异型的膀胱尿路上皮癌通常诊断不足且分期不准确。在经尿道膀胱肿瘤切除术中，其发生率低于25%。大多数病例预后较差，复发和进展率较高，应积极治疗。在此，我们报告一例罕见的膀胱尿路上皮癌脂肪肉瘤样变异型病例，采用部分膀胱切除术和标准盆腔淋巴结清扫术进行治疗。
相似文献
1
Bladder preserving approach for liposarcomatoid variant of transitional urothelial carcinoma.膀胱保留术治疗移行性尿路上皮癌脂肪肉瘤样变体
Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E886-9. doi: 10.5489/cuaj.3167. Epub 2015 Dec 14.
2
Lymph node metastases in patients with urothelial carcinoma variants: influence of the specific variant on nodal histology.尿路上皮癌变异型患者的淋巴结转移：特定变异型对淋巴结组织学的影响。
Urol Oncol. 2015 Jan;33(1):20.e23-20.e29. doi: 10.1016/j.urolonc.2014.06.012. Epub 2014 Jul 18.
3
Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.脉管浸润、输尿管再植和膀胱癌病史与盆腔淋巴结阴性的肌层浸润性膀胱癌行部分膀胱切除术的不良预后相关。
Eur J Surg Oncol. 2013 Oct;39(10):1150-6. doi: 10.1016/j.ejso.2013.04.006. Epub 2013 May 27.
4
The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.变异组织学分化对接受根治性膀胱切除术的淋巴结阳性膀胱癌患者的结外扩散及生存的影响。
Surg Oncol. 2019 Mar;28:208-213. doi: 10.1016/j.suronc.2019.01.008. Epub 2019 Jan 30.
5
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.再次经尿道膀胱肿瘤切除术（re-cTURBT）作为pT1期高级别（HG）疾病复发和进展的风险指标是否有用？一项单中心经验。
Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272.
6
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.在根治性膀胱切除术的 pT1 尿路上皮癌患者中，联合免疫组化标志物的预测价值。
J Urol. 2009 Jul;182(1):78-84; discussion 84. doi: 10.1016/j.juro.2009.02.125. Epub 2009 May 17.
7
The nested variant of bladder transitional cell carcinoma: Review of 12 cases and review of the literature.膀胱移行细胞癌的巢状变异型：12例病例回顾及文献复习
Actas Urol Esp. 2015 Jul-Aug;39(6):387-91. doi: 10.1016/j.acuro.2014.12.003. Epub 2015 Feb 7.
8
[A case of micropapillary bladder carcinoma].[一例微乳头型膀胱癌]
Hinyokika Kiyo. 2012 Jun;58(6):279-82.
9
Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.经尿道切除术、化疗和放疗联合选择性膀胱保留：保留膀胱内Ta、T1和Tis期复发的管理及后果
Urology. 2001 Sep;58(3):380-5. doi: 10.1016/s0090-4295(01)01219-5.
10
Sociodemographic and survival disparities for histologic variants of bladder cancer.膀胱癌组织学亚型的社会人口统计学差异与生存差异
Can J Urol. 2018 Feb;25(1):9179-9185.
本文引用的文献
1
Sarcomatoid Urothelial Carcinoma: A Single Cancer Center Experience.肉瘤样尿路上皮癌：一家癌症中心的经验
World J Oncol. 2011 Aug;2(4):175-180. doi: 10.4021/wjon370w. Epub 2011 Aug 24.
2
Sarcomatoid variant of urothelial carcinoma of the urinary bladder.膀胱尿路上皮癌的肉瘤样变体
J Cancer Res Ther. 2013 Oct-Dec;9(4):571-3. doi: 10.4103/0973-1482.126449.
3
Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.膀胱尿路上皮癌，脂质细胞变异型：临床病理特征和杂合性缺失分析。
Am J Surg Pathol. 2010 Mar;34(3):371-6. doi: 10.1097/PAS.0b013e3181cd385b.
4
Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.尿路上皮膀胱癌的组织学变异型及膀胱癌中的非尿路上皮组织学类型。
Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S193-8. doi: 10.5489/cuaj.1195.
5
Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications.尿路上皮癌的组织学变异型：诊断、治疗及预后意义
Mod Pathol. 2009 Jun;22 Suppl 2:S96-S118. doi: 10.1038/modpathol.2009.26.
6
The many faces of urothelial carcinoma: an update with an emphasis on recently described variants.尿路上皮癌的多种表现形式：最新进展，重点关注近期描述的变异型。
Adv Anat Pathol. 2008 Jul;15(4):218-33. doi: 10.1097/PAP.0b013e31817d79b9.
7
Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection.具有不同组织学分化（混合组织学特征）的尿路上皮癌在经尿道切除术中被检测到时，提示存在局部晚期膀胱癌。
Urology. 2007 Jul;70(1):69-74. doi: 10.1016/j.urology.2007.03.033.
8
Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer.膀胱癌异常分化模式的临床及治疗意义
Expert Rev Anticancer Ther. 2007 Jul;7(7):1015-26. doi: 10.1586/14737140.7.7.1015.
9
Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.尿路上皮癌的脂质细胞变体：5例临床病理及免疫组化研究
Am J Surg Pathol. 2007 May;31(5):770-3. doi: 10.1097/01.pas.0000213410.48805.16.
10
Case of carcinosarcoma of urinary bladder obtained a pathologically complete response by neoadjuvant chemoradiotherapy.一例膀胱癌肉瘤经新辅助放化疗后获得病理完全缓解。
Int J Urol. 2007 Jan;14(1):79-81. doi: 10.1111/j.1442-2042.2006.01600.x.
Zotero 插件